Pharmaceutics · 2025
Tweaking Polybia-MP1: How a Lysine-Histidine Swap Redefines Its Surface Properties.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Miasaki Kenneth M F, Souza Bibiana M, Palma Mario S, Wilke Natalia, Ruggiero Neto João, Alvares Dayane S
Аннотация
Background/Objectives: Polybia-MP1 (MP1) exhibits antimicrobial and anticancer properties. To improve selectivity toward acidic tumor microenvironments, we designed HMP1, a histidine-substituted analog of MP1, aiming to introduce pH-responsive behavior within physiological and pathological pH ranges. Methods: HMP1 was synthesized by replacing all lysine residues in MP1 with histidines. We characterized its surfactant properties and interactions with lipid monolayers composed of DPPC under varying pH and ionic strength conditions. Langmuir monolayer experiments were used to evaluate peptide-induced morphological changes and lipid packing effects at physiologically relevant lateral pressures. Results: HMP1 displayed pH-dependent activity between pH 5.5 and 7.5, inducing significant morphological reorganization of lipid domains without reducing the condensed phase area. Ionic strength modulated these effects, with distinct behaviors observed at low and physiological saline conditions. HMP1 preferentially interacted with cholesterol-enriched membranes, while MP1 did not induce comparable effects under the same conditions, as previously reported, at physiological lateral pressures. HMP1 also exhibited non-hemolytic properties and lower cytotoxicity compared to MP1. Conclusions: The lysine-to-histidine substitution conferred pH sensitivity to HMP1, enabling selective modulation of membrane organization based on lipid composition, packing, pH, and ionic environment. These findings highlight HMP1's potential in targeted therapeutics and pH-responsive drug delivery systems.